How They Won It: Irell Nixes Patent For Prenatal DNA Test

Law360, New York (December 3, 2013, 4:28 PM EST) -- Irell & Manella LLP attorneys took aggressive steps to strike down a patent covering a prenatal DNA test licensed by Sequenom Inc. by citing a host of case law holding that natural phenomena and their discoveries cannot be patented to net a win for molecular diagnostics firm Ariosa Diagnostics Inc.

U.S. District Judge Susan Illston ruled in October that Sequenom had applied only routine and well-established scientific procedures to cell-free fetal DNA, or cffDNA, leaving only the naturally occurring genetic matter as the only innovative portion of the patent-in-suit, U.S. Patent Number 6,258,540.

The restrictions on patenting natural phenomena are clearly laid...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!